Handa Pharmaceuticals (ROCO:6620) Cash per Share : NT$17.94 (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Handa Pharmaceuticals Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Handa Pharmaceuticals's Cash per Share for the quarter that ended in Jun. 2024 was NT$17.94.

Handa Pharmaceuticals Cash per Share Historical Data

The historical data trend for Handa Pharmaceuticals's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Handa Pharmaceuticals Cash per Share Chart

Handa Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash per Share

Get a 7-Day Free Trial

5.38

2.67

2.37

2.79

16.44

Handa Pharmaceuticals Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Cash per Share	Get a 7-Day Free Trial															4.57	15.34	16.44	18.84	17.94

Handa Pharmaceuticals Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Handa Pharmaceuticals's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	2319.486	/	141.1
	=	16.44

Handa Pharmaceuticals's Cash per Share for the quarter that ended in Jun. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	2530.994	/	141.1
	=	17.94

Handa Pharmaceuticals (ROCO:6620) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Handa Pharmaceuticals Cash per Share Related Terms

Thank you for viewing the detailed overview of Handa Pharmaceuticals's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Handa Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Handa Pharmaceuticals Inc (ROCO:6620) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nanke 3rd Road, 3F-1,3F-2, No.23, Xinshi Dist, Tainan, TWN, 74147

Website

http://www.handapharma.com.tw

Handa Pharmaceuticals Inc is a Taiwan based specialty pharmaceutical company. It is engaged in the development of niche drug. The company focuses on the development of high barrier/patentable niche products.

Handa Pharmaceuticals Headlines

No Headlines